Autologous Bone Marrow Cells Derived Engineered Tissues therapy(Chinese University of Hong Kong)
N/A
Report date: 2024/05/07 20:00:09
Base Information
Drug NameAutologous Bone Marrow Cells Derived Engineered Tissues therapy(Chinese University of Hong Kong)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChinese University Of Hong Kong (Cuhk)
China Registration ClassN/A
Develop Information
Active CompaniesChinese University Of Hong Kong (Cuhk)
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A